Danone invests further in gut health and next-generation biotic science
Mont-Saint-Guibert, June 24, 2025 - The Akkermansia Company (TAC) today announces that it has been acquired by Danone, a leading global food and beverage company.
TAC's founding scientists first discovered the biotic strain Akkermansia muciniphila MucT® in 2004 and have since developed it using state-of-the-art technology. They clinically demonstrated its power to reinforce the gut barrier, reduce inflammation, and counteract metabolic disorders such as obesity, diabetes and cardiovascular disease. The company has broad patents protecting the use of the Akkermansia species, including the use of the pasteurized version of the strain, MucT®, which is its most bio-efficacious form.
TAC is successfully expanding business into key markets in Europe, North America and Asia.
"We are very excited about becoming part of the Danone family. It provides us with the resources to accelerate global growth of the pasteurized Akkermansia muciniphila MucT® strain and develop our brands faster", said Michael Oredsson CEO of TAC.
"I am confident that with Danone we will move faster to our goal of giving billions of consumers the opportunity to benefit from improved metabolic health offered by Akkermansia", said TAC's Chief Technology Officer Professor Willem M. DeVos, who discovered Akkermansia and co-founded the company.
For more information: Michael Oredsson, CEO (michael@theakkermansiacompany.com)